Neurogenesis in Huntington's disease: Can studying adult neurogenesis lead to the development of new therapeutic strategies?

Brain Research

Volumn 1406, Issue , 2011, Pages 84-105

  Gil Mohapel, Joana ^a   Simpson, Jessica M ^a   Ghilan, Mohamed ^a   Christie, Brian R ^a,b,c  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adult neurogenesis; Cognitive deficit; Dentate gyrus; Genetic model; Hippocampus; Huntington's disease; Sub ventricular zone; Treatment

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPAKINE; ASIALOERYTHROPOIETIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CENTRAL STIMULANT AGENT; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; FLUOXETINE; IMIPRAMINE; NEUROPEPTIDE Y; NEUROTROPHIC FACTOR; NOGGIN; PAROXETINE; SERTRALINE; UNCLASSIFIED DRUG;

CAG REPEAT; DISEASE COURSE; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG MECHANISM; ENVIRONMENTAL ENRICHMENT; EXERCISE; GENETIC MODEL; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; STEM CELL TRANSPLANTATION; SUBVENTRICULAR ZONE;

ADULT STEM CELLS; ANIMALS; CELL PROLIFERATION; CEREBRAL VENTRICLES; COGNITION DISORDERS; DENTATE GYRUS; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; NEUROGENESIS; NEURONS;

EID: 79960835887     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.06.040     Document Type: Review

References (211)

1. M.A. Aberg, N.D. Aberg, H. Hedbäcker, J. Oscarsson, and P.S. Eriksson Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus J. Neurosci. 20 2000 2896 2903 (Pubitemid 30220315)
2. J. Altman, and G.D. Das Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats J. Comp. Neurol. 124 1965 319 335
3. E.L. Altschuler Strenuous, intensive, long-term exercise does not prevent or delay the onset of Huntington's disease Med. Hypotheses 67 2006 1429 1430 (Pubitemid 44442641)
4. M.A. Andrade, and P. Bork HEAT repeats in the Huntington's disease protein Nat. Genet. 11 1995 115 116
5. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810 (Pubitemid 39434070)
6. A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall Neuronal replacement from endogenous precursors in the adult brain after stroke Nat. Med. 8 2002 963 970 (Pubitemid 35033700)
7. C.M. Batista, T.E. Kippin, S. Willaime-Morawek, M.K. Shimabukuro, W. Akamatsu, and D. van der Kooy A progressive and cell non-autonomous increase in striatal neural stem cells in the Huntington's disease R6/2 mouse J. Neurosci. 26 2006 10452 10460 (Pubitemid 44564595)
8. A. Bauer, K. Zilles, A. Matusch, C. Holzmann, O. Riess, and S. von Hörsten Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation J. Neurochem. 94 2005 639 650 (Pubitemid 41098496)
9. C.L. Benn, E.J. Slow, L.A. Farrell, R. Graham, Y. Deng, M.R. Hayden, and J.H. Cha Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease Neuroscience 147 2007 354 372 (Pubitemid 46907444)
10. A. Benraiss, E. Chmielnicki, K. Lerner, D. Roh, and S.A. Goldman Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain J. Neurosci. 21 2001 6718 6731 (Pubitemid 32781116)
11. M. Björkqvist, M. Fex, E. Renström, N. Wierup, A. Petersén, J. Gil, K. Bacos, N. Popovic, J.Y. Li, F. Sundler, P. Brundin, and H. Mulder The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis Hum. Mol. Genet. 14 2005 565 574 (Pubitemid 40309582)
12. M. Björkqvist, A. Petersén, K. Bacos, J. Isaacs, P. Norlén, J. Gil, N. Popovic, F. Sundler, G.P. Bates, S.J. Tabrizi, P. Brundin, and H. Mulder Progressive alterations in the hypothalamic-pituitary- adrenal axis in the R6/2 transgenic mouse model of Huntington's disease Hum. Mol. Genet. 15 2006 1713 1721 (Pubitemid 43904837)
13. K.B. Bjugstad, W.M. Zawada, S. Goodman, and C.R. Freed IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures J. Inherit. Metab. Dis. 24 2001 631 647 (Pubitemid 33130085)
14. F.J. Bode, M. Stephan, H. Suhling, R. Pabst, R.H. Straub, K.A. Raber, M. Bonin, H.P. Nguyen, O. Riess, A. Bauer, C. Sjoberg, A. Petersén, and S. von Hörsten Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males Hum. Mol. Genet. 17 2008 2595 2609
15. M. Boldrini, M.D. Underwood, R. Hen, G.B. Rosoklija, A.J. Dwork, J. John Mann, and V. Arango Antidepressants increase neural progenitor cells in the human hippocampus Neuropsychopharmacology 34 2009 2376 2389
16. V.J. Bolivar, K. Manley, and A. Messer Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice Behav. Neurosci. 117 2003 1233 1242 (Pubitemid 37549425)
17. V.J. Bolivar, K. Manley, and A. Messer Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice Brain Res. 1005 2004 29 35 (Pubitemid 38388397)
18. K. Brännvall, L. Korhonen, and D. Lindholm Estrogen-receptor- dependent regulation of neural stem cell proliferation and differentiation Mol. Cell. Neurosci. 21 2002 512 520 (Pubitemid 36062736)
19. E. Bruel-Jungerman, C. Rampon, and S. Laroche Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses Rev. Neurosci. 18 2007 93 114
20. N.Y. Calingasan, D.J. Ho, E.J. Wille, M.V. Campagna, J. Ruan, M. Dumont, L. Yang, Q. Shi, G.E. Gibson, and M.F. Beal Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases Neuroscience 153 2008 986 996
21. H.A. Cameron, and R.D. McKay Restoring production of hippocampal neurons in old age Nat. Neurosci. 2 1999 894 897 (Pubitemid 30602603)
22. H.A. Cameron, and R.D. McKay Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus J. Comp. Neurol. 435 2001 406 417 (Pubitemid 32574293)
23. H.A. Cameron, C.S. Woolley, B.S. McEwen, and E. Gould Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat Neuroscience 56 1993 337 344 (Pubitemid 23274753)
24. J.M. Canals, J.R. Pineda, J.F. Torres-Peraza, M. Bosch, R. Martín-Ibañez, M.T. Muñoz, G. Mengod, P. Ernfors, and J. Alberch Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease J. Neurosci. 24 2004 7727 7739 (Pubitemid 39186828)
25. C. Cao, Y. Temel, A. Blokland, H. Ozen, H.W. Steinbusch, R. Vlamings, H.P. Nguyen, S. von Hörsten, C. Schmitz, and V. Visser-Vandewalle Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel Behav. Brain Res. 170 2006 257 261
26. R.J. Carter, L.A. Lione, T. Humby, L. Mangiarini, A. Mahal, G.P. Bates, S.B. Dunnett, and A.J. Morton Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation J. Neurosci. 19 1999 3248 3257 (Pubitemid 29174016)
27. R.J. Carter, M.J. Hunt, and A.J. Morton Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene Mov. Disord. 15 2000 925 937
28. Cepeda, C.; Cummings, D.M.; Hickey, M.A.; Kleiman-Weiner, M.; Chen, J.Y.; Watson, J.B.; Levine, M.S.; 2010. Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and Ampakines. PLoS Curr. 20, RRN1182.
29. J.H. Cha Transcriptional dysregulation in Huntington's disease Trends Neurosci. 23 2000 387 392
30. J.H. Cha, C.M. Kosinski, J.A. Kerner, S.A. Alsdorf, L. Mangiarini, S.W. Davies, J.B. Penney, G.P. Bates, and A.B. Young Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene Proc. Natl. Acad. Sci. U. S. A. 95 1998 6480 6485 (Pubitemid 28249039)
31. Chari S.; Quraishi S. H.; & Jainer A. K. (2003). Fluoxetine-induced exacerbation of chorea in Huntington's disease? A case report. Pharmacopsychiatry. Germany
32. S.R. Cho, A. Benraiss, E. Chmielnicki, A. Samdani, A. Economides, and S.A. Goldman Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease J. Clin. Invest. 117 2007 2889 2902 (Pubitemid 47529619)
33. Christie, and Cameron Neurogenesis in the adult hippocampus Hippocampus 16 2006 199 207
34. Q. Chu-LaGraff, X. Kang, and A. Messer Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice Brain Res. Bull. 56 2001 307 312 (Pubitemid 33069355)
35. A. Ciammola, J. Sassone, M. Cannella, S. Calza, B. Poletti, L. Frati, F. Squitieri, and V. Silani Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B 2007 574 577 (Pubitemid 46983172)
36. P.G. Como, A.J. Rubin, C.F. O'Brien, K. Lawler, C. Hickey, A.E. Rubin, R. Henderson, M.P. McDermott, M. McDermott, K. Steinberg, and I. Shoulson A controlled trial of fluoxetine in nondepressed patients with Huntington's disease Mov. Disord. 12 1997 397 401 (Pubitemid 27216139)
37. P. Conforti, C. Ramos, B.L. Apostol, D.A. Simmons, H.P. Nguyen, O. Riess, L.M. Thompson, C. Zuccato, and E. Cattaneo Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347 Mol. Cell. Neurosci. 39 2008 1 7
38. L. Covolan, L.T. Ribeiro, B.M. Longo, and L.E. Mello Cell damage and neurogenesis in the dentate granule cell layer of adult rats after pilocarpine- or kainate-induced status epilepticus Hippocampus 10 2000 169 180 (Pubitemid 30216354)
39. H. Cremer, G. Chazal, P.M. Lledo, G. Rougon, M.F. Montaron, W. Mayo, M. Le Moal, and D.N. Abrous PSA-NCAM: an important regulator of hippocampal plasticity Int. J. Dev. Neurosci. 18 2000 213 220 (Pubitemid 30129195)
40. Z.R. Crook, and D. Housman Huntington's disease: can mice lead the way to treatment? Neuron 69 2011 423 435
41. M.A. Curtis, E.B. Penney, A.G. Pearson, W.M. van Roon-Mom, N.J. Butterworth, M. Dragunow, B. Connor, and R.L. Faull Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain Proc. Natl. Acad. Sci. U. S. A. 100 2003 9023 9027 (Pubitemid 36899216)
42. M.A. Curtis, E.B. Penney, J. Pearson, M. Dragunow, B. Connor, and R.L. Faull The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain Neuroscience 132 2005 777 788
43. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548 (Pubitemid 27347243)
44. M. Decressac, B. Wright, B. David, P. Tyers, M. Jaber, R.A. Barker, and A. Gaillard Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis Hippocampus 2010 2010 Jan 21. doi: 10.1002/hipo.20765. [Electronic publication ahead of print]
45. M. Decressac, B. Wright, P. Tyers, A. Gaillard, and R.A. Barker Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease Exp. Neurol. 226 2010 24 32
46. W. Deng, J.B. Aimone, and F.H. Gage New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat. Rev. Neurosci. 11 2010 339 350
47. K. Dewhurst, J.E. Oliver, and A.L. McKnight Socio-psychiatric consequences of Huntington's disease Br. J. Psychiatry 116 1970 255 258
48. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993 (Pubitemid 27449140)
49. W. Duan, Z. Guo, H. Jiang, B. Ladenheim, X. Xu, J.L. Cadet, and M.P. Mattson Paroxetine retards disease onset and progression in Huntingtin mutant mice Ann. Neurol. 55 2004 590 594 (Pubitemid 38391979)
50. W. Duan, Q. Peng, N. Masuda, E. Ford, E. Tryggestad, B. Ladenheim, M. Zhao, J.L. Cadet, J. Wong, and C.A. Ross Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease Neurobiol. Dis. 30 2008 312 322
51. K. Duff, J.S. Paulsen, L.J. Beglinger, D.R. Langbehn, J.C. Stout Predict-HD Investigators of the Huntington Study Group Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study Biol. Psychiatry 62 2007 1341 1346 (Pubitemid 350180721)
52. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, S.M. Hersch, M.M. Mouradian, A.B. Young, N. Tanese, and D. Krainc Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243 (Pubitemid 34680312)
53. S.B. Dunnett, and A.E. Rosser Stem cell transplantation for Huntington's disease Exp. Neurol. 203 2007 279 292 (Pubitemid 46149598)
54. C.T. Ekdahl, J.H. Claasen, S. Bonde, Z. Kokaia, and O. Lindvall Inflammation is detrimental for neurogenesis in adult brain Proc. Natl. Acad. Sci. U. S. A. 100 2003 13632 13637 (Pubitemid 37444791)
55. J. Fallon, S. Reid, R. Kinyamu, I. Opole, R. Opole, J. Baratta, M. Korc, T.L. Endo, A. Duong, G. Nguyen, M. Karkehabadhi, D. Twardzik, S. Patel, and S. Loughlin In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain Prod. Natl. Acad. Sci. U. S. A. 97 2000 14686 14691 (Pubitemid 32016636)
56. V. Fedele, L. Roybon, U. Nordström, J.Y. Li, and P. Brundin Neurogenesis in R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1 Neuroscience 173 2010 76 81
57. I. Ferrer, E. Goutan, C. Marín, M.J. Rey, and T. Ribalta Brain-derived neurotrophic factor in Huntington disease Brain Res. 866 2000 257 261 (Pubitemid 30313028)
58. S.E. Folstein, and M.F. Folstein Psychiatric features of Huntington's disease: recent approaches and findings Psychiatr. Dev. 1 1983 193 205
59. S. Folstein, M.H. Abbott, G.A. Chase, B.A. Jensen, and M.F. Folstein The association of affective disorder with Huntington's disease in a case series and in families Psychol. Med. 13 1983 537 542 (Pubitemid 13019019)
60. L.R. Gauthier, B.C. Charrin, M. Borrell-Pagès, J.P. Dompierre, H. Rangone, F.P. Cordelières, J. De Mey, M.E. MacDonald, V. Lessmann, S. Humbert, and F. Saudou Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 2004 127 138 (Pubitemid 38902819)
61. H.E. Gibson, K. Reim, N. Brose, A.J. Morton, and S. Jones A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse Eur. J. Neurosci. 22 2005 1701 1712 (Pubitemid 41482958)
62. J.M. Gil, and A.C. Rego Mechanisms of neurodegeneration in Huntington's disease Eur. J. Neurosci. 27 2008 2803 2820 (Pubitemid 351832229)
63. J.M. Gil, and A.C. Rego The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease Brain Res. Rev. 59 2009 410 431
64. J.M. Gil, M. Leist, N. Popovic, P. Brundin, and A. Petersén Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice BMC Neurosci. 5 2004 17
65. J.M. Gil, P. Mohapel, I.M. Araújo, N. Popovic, J.Y. Li, P. Brundin, and A. Petersén Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice Neurobiol. Dis. 20 2005 744 751 (Pubitemid 41619351)
66. Gil-Mohapel, J.M.; 2001. Screening of therapeutic strategies for Huntington's Disease in YAC128 transgenic mice. CNS Neurosci. Ther. 2011 Feb 16. doi: 10.1111/j.1755-5949.2011.00246.x. [Electronic publication ahead of print].
67. J. Gil-Mohapel, J.M. Simpson, and B.R. Christie Modulation of adult neurogenesis by physical exercise and environmental enrichment: insights for the treatment of neurological disorders J. Kunlin, Nervous System Diseases Vol. 2010 Transworld Research Network Kerala, India 125 150
68. J.D. Godin, K. Colombo, M. Molina-Calavita, G. Keryer, D. Zala, B.C. Charrin, P. Dietrich, M.L. Volvert, F. Guillemot, I. Dragatsis, Y. Bellaiche, F. Saudou, L. Nguyen, and S. Humbert Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis Neuron 67 2010 392 406
69. E. Gould, D.C. Daniels, H.A. Cameron, and B.S. McEwen Expression of adrenal steroid receptors by newly born cells and pyknotic cells in the dentate gyrus of the postnatal rat Mol. Cell. Neurosci. 3 1992 44 48
70. E. Gould, P. Tanapat, B.S. McEwen, G. Flügge, and E. Fuchs Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress Proc. Natl. Acad. Sci. U. S. A. 95 1998 3168 3171 (Pubitemid 28135873)
71. E. Gould, A. Beylin, P. Tanapat, A. Reeves, and T.J. Shors Learning enhances adult neurogenesis in the hippocampal formation Nat. Neurosci. 2 1999 260 265 (Pubitemid 30491297)
72. R.K. Graham, Y. Deng, E.J. Slow, B. Haigh, N. Bissada, G. Lu, J. Pearson, J. Shehadeh, L. Bertram, Z. Murphy, S.C. Warby, C.N. Doty, S. Roy, C.L. Wellington, B.R. Leavitt, L.A. Raymond, D.W. Nicholson, and M.R. Hayden Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin Cell 125 2006 1179 1191 (Pubitemid 43866195)
73. W.P. Gray, and L.E. Sundstrom Kainic acid increases the proliferation of granule cell progenitors in the dentate gyrus of the adult rat Brain Res. 790 1998 52 59 (Pubitemid 28234487)
74. M. Gray, D.I. Shirasaki, C. Cepeda, V.M. André, B. Wilburn, X.H. Lu, J. Tao, I. Yamazaki, S.H. Li, Y.E. Sun, X.J. Li, M.S. Levine, and X.W. Yang Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice J. Neurosci. 28 2008 6182 6195
75. H.E. Grote, N.D. Bull, M.L. Howard, A. van Dellen, C. Blakemore, P.F. Bartlett, and A.J. Hannan Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine Eur. J. Neurosci. 22 2005 2081 2088 (Pubitemid 41579396)
76. C.A. Gutekunst, A.I. Levey, C.J. Heilman, W.L. Whaley, H. Yi, N.R. Nash, H.D. Rees, J.J. Madden, and S.M. Hersch Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies Proc. Natl. Acad. Sci. U. S. A. 92 1995 8710 8714
77. O. Hansson, A. Petersén, M. Leist, P. Nicotera, R.F. Castilho, and P. Brundin Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity Proc. Natl. Acad. Sci. U. S. A. 96 1999 8727 8732 (Pubitemid 29354859)
78. K.W. Heathfield Huntington's chorea. Investigation into the prevalence of this disease in the area covered by the North East Metropolitan Regional Hospital Board Brain 90 1967 203 232
79. D. Helmlinger, G. Yvert, S. Picaud, K. Merienne, J. Sahel, J.L. Mandel, and D. Devys Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice Hum. Mol. Genet. 11 2002 3351 3359 (Pubitemid 36054663)
80. M.Y. Heng, P.J. Detloff, and R.L. Albin Rodent genetic models of Huntington disease Neurobiol. Dis. 32 2008 1 9
81. M.A. Hickey, and M.F. Chesselet The use of transgenic and knock-in mice to study Huntington's disease Cytogenet. Genome Res. 100 2003 276 286 (Pubitemid 37467815)
82. M.A. Hickey, G.P. Reynolds, and A.J. Morton The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease J. Neurochem. 81 2002 46 59 (Pubitemid 34808853)
83. E. Hockly, P.M. Cordery, B. Woodman, A. Mahal, A. van Dellen, C. Blakemore, C.M. Lewis, A.J. Hannan, and G.P. Bates Environmental enrichment slows disease progression in R6/2 Huntington's disease mice Ann. Neurol. 51 2002 235 242 (Pubitemid 34111446)
84. J.G. Hodgson, N. Agopyan, C.A. Gutekunst, B.R. Leavitt, F. LePiane, R. Singaraja, D.J. Smith, N. Bissada, K. McCutcheon, J. Nasir, L. Jamot, X.J. Li, M.E. Stevens, E. Rosemond, J.C. Roder, A.G. Phillips, E.M. Rubin, S.M. Hersch, and M.R. Hayden A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 23 1999 181 192 (Pubitemid 29262475)
85. G. Hoffner, P. Kahlem, and P. Djian Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease J. Cell Sci. 115 2002 941 948 (Pubitemid 34257379)
86. G.U. Höglinger, P. Rizk, M.P. Muriel, C. Duyckaerts, W.H. Oertel, I. Caille, and E.C. Hirsch Dopamine depletion impairs precursor cell proliferation in Parkinson disease Nat. Neurosci. 7 2004 726 735 (Pubitemid 38859057)
87. M.S. Hurlbert, W. Zhou, C. Wasmeier, F.G. Kaddis, J.C. Hutton, and C.R. Freed Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes Diabetes 48 1999 649 651 (Pubitemid 29106885)
88. C. Iannicola, S. Moreno, S. Oliverio, R. Nardacci, A. Ciofi-Luzzatto, and M. Piacentini Early alterations in gene expression and cell morphology in a mouse model of Huntington's disease J. Neurochem. 75 2000 830 839 (Pubitemid 30485467)
89. M. Ingvar, J. Ambros-Ingerson, M. Davis, R. Granger, M. Kessler, G.A. Rogers, R.S. Schehr, and G. Lynch Enhancement by an ampakine of memory encoding in humans Exp. Neurol. 146 1997 553 559 (Pubitemid 27381863)
90. P. Jensen, S.A. Sørensen, K. Fenger, and T.G. Bolwig A study of psychiatric morbidity in patients with Huntington's disease, their relatives, and controls. Admissions to psychiatric hospitals in Denmark from 1969 to 1991 Br. J. Psychiatry 163 1993 790 797 (Pubitemid 23352974)
91. K. Jin, L. Xie, J. Childs, Y. Sun, X.O. Mao, A. Logvinova, and D.A. Greenberg Cerebral neurogenesis is induced by intranasal administration of growth factors Ann. Neurol. 53 2003 405 409 (Pubitemid 36258647)
92. K. Jin, M. LaFevre-Bernt, Y. Sun, S. Chen, J. Gafni, D. Crippen, A. Logvinova, C.A. Ross, D.A. Greenberg, and L.M. Ellerby FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 18189 18194 (Pubitemid 41798523)
93. M. Kandasamy, S. Couillard-Despres, K.A. Raber, M. Stephan, B. Lehner, B. Winner, Z. Kohl, F.J. Rivera, H.P. Nguyen, O. Riess, U. Bogdahn, J. Winkler, S. von Hörsten, and L. Aigner Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease J. Neuropathol. Exp. Neurol. 69 2010 717 728
94. O. Kántor, Y. Temel, C. Holzmann, K. Raber, H.P. Nguyen, C. Cao, H.O. Türkoglu, B.P. Rutten, V. Visser-Vandewalle, H.W. Steinbusch, A. Blokland, H. Korr, O. Riess, S. von Hörsten, and C. Schmitz Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats Neurobiol. Dis. 22 2006 538 547 (Pubitemid 43832125)
95. M.S. Kaplan, and J.W. Hinds Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs Science 197 1977 1092 1094 (Pubitemid 8170019)
96. G. Kempermann, H.G. Kuhn, and F.H. Gage More hippocampal neurons in adult mice living in an enriched environment Nature 386 1997 493 495 (Pubitemid 27164074)
97. G. Kempermann, L. Wiskott, and F.H. Gage Functional significance of adult neurogenesis Curr. Opin. Neurobiol. 14 2004 186 191 (Pubitemid 38479935)
98. M. Kim, S.T. Lee, K. Chu, and S.U. Kim Stem cell-based cell therapy for Huntington disease: a review Neuropathology 28 2008 1 9
99. T.E. Kippin, S. Kapur, and D. van der Kooy Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs J. Neurosci. 25 2005 5815 5823 (Pubitemid 40847894)
100. S.C. Kirkwood, J.L. Su, P. Conneally, and T. Foroud Progression of symptoms in the early and middle stages of Huntington disease Arch. Neurol. 58 2001 273 278 (Pubitemid 32163165)
101. J.Z. Kiss, E. Troncoso, Z. Djebbara, L. Vutskits, and D. Muller The role of neural cell adhesion molecules in plasticity and repair Brain Res. Brain Res. Rev. 36 2001 175 184 (Pubitemid 33020747)
102. G.J. Klapstein, R.S. Fisher, H. Zanjani, C. Cepeda, E.S. Jokel, M.F. Chesselet, and M.S. Levine Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice J. Neurophysiol. 86 2001 2667 2677 (Pubitemid 33139038)
103. P. Klivenyi, A.A. Starkov, N.Y. Calingasan, G. Gardian, S.E. Browne, L. Yang, P. Bubber, G.E. Gibson, M.S. Patel, and M.F. Beal Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity J. Neurochem. 88 2004 1352 1360 (Pubitemid 38366910)
104. Z. Kohl, M. Kandasamy, B. Winner, R. Aigner, C. Gross, S. Couillard-Despres, U. Bogdahn, L. Aigner, and J. Winkler Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease Brain Res. 1155 2007 24 33 (Pubitemid 46891433)
105. Z. Kohl, M. Regensburger, R. Aigner, M. Kandasamy, B. Winner, L. Aigner, and J. Winkler Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease BMC Neurosci. 11 2010 114
106. S. Kuemmerle, C.A. Gutekunst, A.M. Klein, X.J. Li, S.H. Li, M.F. Beal, S.M. Hersch, and R.J. Ferrante Huntington aggregates may not predict neuronal death in Huntington's disease Ann. Neurol. 46 1999 842 849
107. H.G. Kuhn, H. Dickinson-Anson, and F.H. Gage Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation J. Neurosci. 16 1996 2027
108. S.E. Lazic, H. Grote, R.J. Armstrong, C. Blakemore, A.J. Hannan, A. van Dellen, and R.A. Barker Decreased hippocampal cell proliferation in R6/1 Huntington's mice Neuroreport 15 2004 811 813 (Pubitemid 38453463)
109. S.E. Lazic, H.E. Grote, C. Blakemore, A.J. Hannan, A. van Dellen, W. Phillips, and R.A. Barker Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment Eur. J. Neurosci. 23 2006 1829 1838
110. M.S. Levine, G.J. Klapstein, A. Koppel, E. Gruen, C. Cepeda, M.E. Vargas, E.S. Jokel, E.M. Carpenter, H. Zanjani, R.S. Hurst, A. Efstratiadis, S. Zeitlin, and M.F. Chesselet Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease J. Neurosci. Res. 58 1999 515 532 (Pubitemid 29530435)
111. M.S. Levine, C. Cepeda, M.A. Hickey, S.M. Fleming, and M.F. Chesselet Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect Trends Neurosci. 27 2004 691 697 (Pubitemid 39335840)
112. S.H. Li, and X.J. Li Huntingtin-protein interactions and the pathogenesis of Huntington's disease Trends Genet. 20 2004 146 154
113. H. Li, S.H. Li, A.L. Cheng, L. Mangiarini, G.P. Bates, and X.J. Li Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice Hum. Mol. Genet. 8 1999 1227 1236 (Pubitemid 29328991)
114. J.Y. Li, N. Popovic, and P. Brundin The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies NeuroRx 2 2005 447 464 (Pubitemid 41444878)
115. D.C. Lie, H. Song, S.A. Colamarino, G.L. Ming, and F.H. Gage Neurogenesis in the adult brain: new strategies for central nervous system diseases Annu. Rev. Pharmacol. Toxicol. 44 2004 399 421 (Pubitemid 38263847)
116. C.H. Lin, S. Tallaksen-Greene, W.M. Chien, J.A. Cearley, W.S. Jackson, A.B. Crouse, S. Ren, X.J. Li, R.L. Albin, and P.J. Detloff Neurological abnormalities in a knock-in mouse model of Huntington's disease Hum. Mol. Genet. 10 2001 137 144 (Pubitemid 32098123)
117. O. Lindvall, and Z. Kokaia Stem cells for the treatment of neurological disorders Nature 441 2006 1094 1096 (Pubitemid 43990722)
118. L.A. Lione, R.J. Carter, M.J. Hunt, G.P. Bates, A.J. Morton, and S.B. Dunnett Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation J. Neurosci. 19 1999 10428 10437 (Pubitemid 30228050)
119. M. Liu, S.J. Pleasure, A.E. Collins, J.L. Noebels, F.J. Naya, M.J. Tsai, and D.H. Lowenstein Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy Proc. Natl. Acad. Sci. U. S. A. 97 2000 865 870 (Pubitemid 30070401)
120. M.T. Lorincz, and V.A. Zawistowski Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells Mol. Cell. Neurosci. 40 2009 1 13
121. H.G. Lüesse, J. Schiefer, A. Spruenken, C. Puls, F. Block, and C.M. Kosinski Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus Behav. Brain Res. 126 2001 185 195 (Pubitemid 33009421)
122. R. Luthi-Carter, A. Strand, N.L. Peters, S.M. Solano, Z.R. Hollingsworth, A.S. Menon, A.S. Frey, B.S. Spektor, E.B. Penney, G. Schilling, C.A. Ross, D.R. Borchelt, S.J. Tapscott, A.B. Young, J.H. Cha, and J.M. Olson Decreased expression of striatal signaling genes in a mouse model of Huntington's disease Hum. Mol. Genet. 9 2000 1259 1271 (Pubitemid 30312475)
123. G. Lynch, E.A. Kramar, C.S. Rex, Y. Jia, D. Chappas, C.M. Gall, and D.A. Simmons Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease J. Neurosci. 27 2007 4424 4434 (Pubitemid 46640726)
124. K.S. MacMillan, J. Naidoo, J. Liang, L. Melito, N.S. Williams, L. Morlock, P.J. Huntington, S.J. Estill, J. Longgood, G.L. Becker, S.L. McKnight, A.A. Pieper, J.K. De Brabander, and J.M. Ready Development of proneurogenic, neuroprotective small molecules J. Am. Chem. Soc. 133 2011 1428 1437
125. J.E. Malberg, A.J. Eisch, E.J. Nestler, and R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J. Neurosci. 20 2000 9104 9110 (Pubitemid 32042912)
126. H. Manev, T. Uz, N.R. Smalheiser, and R. Manev Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro Eur. J. Pharmacol. 411 2001 67 70 (Pubitemid 32013113)
127. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, and G.P. Bates Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice 1996
128. E. Marcora, K. Gowan, and J.E. Lee Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2 Proc. Natl. Acad. Sci. U. S. A. 100 2003 9578 9583 (Pubitemid 37033970)
129. M.W. Marlatt, P.J. Lucassen, and H. van Praag Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice Brain Res. 1341 2010 93 99
130. C.A. Meade, Y.P. Deng, F.R. Fusco, N. Del Mar, S. Hersch, D. Goldowitz, and A. Reiner Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice J. Comp. Neurol. 449 2002 241 269 (Pubitemid 34734283)
131. L.B. Menalled, and M.F. Chesselet Mouse models of Huntington's disease Trends Pharmacol. Sci. 23 2002 32 39 (Pubitemid 34135973)
132. M.W. Miller, and R.S. Nowakowski Use of bromodeoxyuridine- immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system Brain Res. 457 1988 44 52
133. C. Mirescu, and E. Gould Stress and adult neurogenesis Hippocampus 16 2006 233 238
134. P. Mohapel, and P. Brundin Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia Parkinsonism Relat. Disord. 10 2004 259 264 (Pubitemid 38757805)
135. L. Moraes, L.E. de Moraes Mello, M.K. Shimabukuro, C.M. de Castro Batista, and R. Mendez-Otero Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model Neuropathology 29 2009 140 147
136. A.J. Morton, N.I. Wood, M.H. Hastings, C. Hurelbrink, R.A. Barker, and E.S. Maywood Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease J. Neurosci. 25 2005 157 163 (Pubitemid 40110776)
137. J.R. Munoz, B.R. Stoutenger, A.P. Robinson, J.L. Spees, and D.J. Prockop Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice Proc. Natl. Acad. Sci. U. S. A. 102 2005 18171 18176 (Pubitemid 41798520)
138. K.P. Murphy, R.J. Carter, L.A. Lione, L. Mangiarini, A. Mahal, G.P. Bates, S.B. Dunnett, and A.J. Morton Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation J. Neurosci. 20 2000 5115 5123 (Pubitemid 30421714)
139. A.F. Neuwald, and T. Hirano HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions Genome Res. 10 2000 1445 1452
140. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J. Neurosci. 15 1995 7539 7547
141. J. Nithianantharajah, C. Barkus, N. Vijiaratnam, O. Clement, and A.J. Hannan Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice Am. J. Geriatr. Psychiatry 17 2009 196 209
142. A.K. Olson, B.D. Eadie, C. Ernst, and B.R. Christie Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways Hippocampus 16 2006 250 260
143. T.D. Palmer, J. Ray, and F.H. Gage FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain Mol. Cell. Neurosci. 6 1995 474 486
144. T.Y. Pang, N.C. Stam, J. Nithianantharajah, M.L. Howard, and A.J. Hannan Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice Neuroscience 141 2006 569 584 (Pubitemid 44066652)
145. T.Y. Pang, X. Du, M.S. Zajac, M.L. Howard, and A.J. Hannan Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease Hum. Mol. Genet. 18 2009 753 766
146. J.M. Parent, Z.S. Vexler, C. Gong, N. Derugin, and D.M. Ferriero Rat forebrain neurogenesis and striatal neuron replacement after focal stroke Ann. Neurol. 52 2002 802 813 (Pubitemid 35403191)
147. J.H. Park, and G. Enikolopov Transient elevation of adult hippocampal neurogenesis after dopamine depletion Exp. Neurol. 222 2010 267 276
148. V. Pencea, K.D. Bingaman, S.J. Wiegand, and M.B. Luskin Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus J. Neurosci. 21 2001 6706 6717 (Pubitemid 32781115)
149. Q. Peng, N. Masuda, M. Jiang, Q. Li, M. Zhao, C.A. Ross, and W. Duan The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model Exp. Neurol. 210 2008 154 163
150. M. Perez-Martin, I. Azcoitia, J.L. Trejo, A. Sierra, and L.M. Garcia-Segura An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat Eur. J. Neurosci. 18 2003 923 930 (Pubitemid 37059702)
151. A. Petersén, and M. Björkqvist Hypothalamic-endocrine aspects in Huntington's disease Eur. J. Neurosci. 24 2006 961 967 (Pubitemid 44268127)
152. A. Petersén, and P. Brundin Huntington's disease: the mystery unfolds? Int. Rev. Neurobiol. 53 2002 315 339
153. A. Petersén, O. Hansson, Z. Puschban, E. Sapp, N. Romero, R.F. Castilho, D. Sulzer, M. Rice, M. DiFiglia, S. Przedborski, and P. Brundin Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine Eur. J. Neurosci. 14 2001 1425 1435 (Pubitemid 35463710)
154. A. Petersén, Z. Puschban, J. Lotharius, B. NicNiocaill, P. Wiekop, W.T. O'Connor, and P. Brundin Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice Neurobiol. Dis. 11 2002 134 146 (Pubitemid 35435681)
155. A. Petersén, J. Gil, M.L. Maat-Schieman, M. Björkqvist, H. Tanila, I.M. Araújo, R. Smith, N. Popovic, N. Wierup, P. Norlén, J.Y. Li, R.A. Roos, F. Sundler, H. Mulder, and P. Brundin Orexin loss in Huntington's disease Hum. Mol. Genet. 14 2005 39 47 (Pubitemid 40123461)
156. S. Pflanz, J.A. Besson, K.P. Ebmeier, and S. Simpson The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression Acta Psychiatr. Scand. 83 1991 53 60
157. W. Phillips, A.J. Morton, and R.A. Barker Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment J. Neurosci. 25 2005 11564 11576 (Pubitemid 43098449)
158. W. Phillips, A. Jennifer Morton, and R.A. Barker Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease Neuroreport 17 2006 1623 1627 (Pubitemid 44454769)
159. M.A. Pouladi, R.K. Graham, J.M. Karasinska, Y. Xie, R.D. Santos, A. Petersén, and M.R. Hayden Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin Brain 132 2009 919 932
160. S. Ramaswamy, J.L. McBride, and J.H. Kordower Animal models of Huntington's disease ILAR J. 48 2007 356 373 (Pubitemid 350194368)
161. P.H. Reddy, M. Williams, V. Charles, L. Garrett, L. Pike-Buchanan, W.O. Whetsell, G. Miller, and D.A. Tagle Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA Nat. Genet. 20 1998 198 202 (Pubitemid 28455456)
162. G.P. Reynolds, C.F. Dalton, C.L. Tillery, L. Mangiarini, S.W. Davies, and G.P. Bates Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation J. Neurochem. 72 1999 1773 1776 (Pubitemid 29140856)
163. H.D. Rosas, W.J. Koroshetz, Y.I. Chen, C. Skeuse, M. Vangel, M.E. Cudkowicz, K. Caplan, K. Marek, L.J. Seidman, N. Makris, B.G. Jenkins, and J.M. Goldstein Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis Neurology 60 2003 1615 1620 (Pubitemid 36618087)
164. F. Saudou, S. Finkbeiner, D. Devys, and M.E. Greenberg Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions Cell 95 1998 55 66
165. G. Schilling, M.W. Becher, A.H. Sharp, H.A. Jinnah, K. Duan, J.A. Kotzuk, H.H. Slunt, T. Ratovitski, J.K. Cooper, N.A. Jenkins, N.G. Copeland, D.L. Price, C.A. Ross, and D.R. Borchelt Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin Hum. Mol. Genet. 8 1999 397 407 (Pubitemid 29097327)
166. G. Schilling, A.V. Savonenko, M.L. Coonfield, J.L. Morton, E. Vorovich, A. Gale, C. Neslon, N. Chan, M. Eaton, D. Fromholt, C.A. Ross, and D.R. Borchelt Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice Exp. Neurol. 187 2004 137 149 (Pubitemid 38470019)
167. P.F. Shelbourne, N. Killeen, R.F. Hevner, H.M. Johnston, L. Tecott, M. Lewandoski, M. Ennis, L. Ramirez, Z. Li, C. Iannicola, D.R. Littman, and R.M. Myers A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice Hum. Mol. Genet. 8 1999 763 774 (Pubitemid 29189043)
168. D.A. Simmons, C.S. Rex, L. Palmer, V. Pandyarajan, V. Fedulov, C.M. Gall, and G. Lynch Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice Proc. Natl. Acad. Sci. U. S. A. 106 2009 4906 4911
169. J.M. Simpson, J. Gil-Mohapel, M.A. Pouladi, M. Ghilan, Y. Xie, M.R. Hayden, and B.R. Christie Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease Neurobiol. Dis. 41 2011 249 260
170. J.R. Slaughter, M.P. Martens, and K.A. Slaughter Depression and Huntington's disease: prevalence, clinical manifestations, etiology, and treatment CNS Spectr. 6 2001 306 326 (Pubitemid 32574137)
171. E.J. Slow, J. van Raamsdonk, D. Rogers, S.H. Coleman, R.K. Graham, Y. Deng, R. Oh, N. Bissada, S.M. Hossain, Y.Z. Yang, X.J. Li, E.M. Simpson, C.A. Gutekunst, B.R. Leavitt, and M.R. Hayden Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease Hum. Mol. Genet. 12 2003 1555 1567 (Pubitemid 36857303)
172. E.J. Slow, R.K. Graham, A.P. Osmand, R.S. Devon, G. Lu, Y. Deng, J. Pearson, K. Vaid, N. Bissada, R. Wetzel, B.R. Leavitt, and M.R. Hayden Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions Proc. Natl. Acad. Sci. U. S. A. 102 2005 11402 11407 (Pubitemid 41153832)
173. B.R. Snyder, A.M. Chiu, D.J. Prockop, and A.W. Chan Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease PLoS One 5 2010 e9347
174. J. Spampanato, X. Gu, X.W. Yang, and I. Mody Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease Neuroscience 157 2008 606 620
175. E. Spargo, I.P. Everall, and P.L. Lantos Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection J. Neurol. Neurosurg. Psychiatry 56 1993 487 491 (Pubitemid 23171778)
176. T.L. Spires, H.E. Grote, S. Garry, P.M. Cordery, A. Van Dellen, C. Blakemore, and A.J. Hannan Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice Eur. J. Neurosci. 19 2004 2799 2807 (Pubitemid 38746396)
177. E.C. Stack, J.K. Kubilus, K. Smith, K. Cormier, S.J. Del Signore, E. Guelin, H. Ryu, S.M. Hersch, and R.J. Ferrante Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice J. Comp. Neurol. 490 2005 354 370 (Pubitemid 41232558)
178. L.J. Steward, K.E. Bufton, P.C. Hopkins, W.E. Davies, and N.M. Barnes Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington's disease Eur. J. Pharmacol. 242 1993 137 143 (Pubitemid 23288792)
179. A.D. Strand, Z.C. Baquet, A.K. Aragaki, P. Holmans, L. Yang, C. Cleren, M.F. Beal, L. Jones, C. Kooperberg, J.M. Olson, and K.R. Jones Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration J. Neurosci. 27 2007 11758 11768 (Pubitemid 350006916)
180. F.R. Sullivan, E.D. Bird, M. Alpay, and J.H. Cha Remotivation therapy and Huntington's disease J. Neurosci. Nurs. 33 2001 136 142
181. A.S. Tattersfield, R.J. Croon, Y.W. Liu, A.P. Kells, R.L. Faull, and B. Connor Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease Neuroscience 127 2004 319 332 (Pubitemid 38950647)
182. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group Cell 72 1993 971 983
183. G. Tomasevic, F. Kamme, and T. Wieloch Changes in proliferating cell nuclear antigen, a protein involved in DNA repair, in vulnerable hippocampal neurons following global cerebral ischemia Brain Res. Mol. Brain Res. 60 1998 168 176 (Pubitemid 28466582)
184. H.J. Tuominen, J. Tiihonen, and K. Wahlbeck Glutamatergic drugs for schizophrenia Cochrane Database Syst. Rev. 2006 CD003730
185. M. Turmaine, A. Raza, A. Mahal, L. Mangiarini, G.P. Bates, and S.W. Davies Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease Proc. Natl. Acad. Sci. U. S. A. 97 2000 8093 8097 (Pubitemid 30460778)
186. A. van Dellen, C. Blakemore, R. Deacon, D. York, and A.J. Hannan Delaying the onset of Huntington's in mice Nature 404 2000 721 722 (Pubitemid 30212388)
187. A. van Dellen, P.M. Cordery, T.L. Spires, C. Blakemore, and A.J. Hannan Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease BMC Neurosci. 9 2008 34
188. K. van der Borght, and P. Brundin Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease Exp. Neurol. 204 2007 473 478 (Pubitemid 46330273)
189. J.M. van der Burg, K. Bacos, N.I. Wood, A. Lindqvist, N. Wierup, B. Woodman, J.I. Wamsteeker, R. Smith, T. Deierborg, M.J. Kuhar, G.P. Bates, H. Mulder, C. Erlanson-Albertsson, A.J. Morton, P. Brundin, A. Petersén, and M. Björkqvist Increased metabolism in the R6/2 mouse model of Huntington's disease Neurobiol. Dis. 29 2008 41 51 (Pubitemid 350180481)
190. H. Van Praag, B.R. Christie, T.J. Sejnowski, and F.H. Gage Running enhances neurogenesis, learning, and long-term potentiation in mice Proc. Natl. Acad. Sci. U. S. A. 96 1999 13427 13431
191. H. van Praag, G. Kempermann, and F.H. Gage Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus Nat. Neurosci. 2 1999 266 270 (Pubitemid 30491298)
192. J.M. Van Raamsdonk, Z. Murphy, E.J. Slow, B.R. Leavitt, and M.R. Hayden Selective degeneration of nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease Hum. Mol. Genet. 14 2005 3823 3835 (Pubitemid 43020084)
193. J.M. Van Raamsdonk, J. Pearson, C.D. Bailey, D.A. Rogers, G.V. Johnson, and M.R. Hayden Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntingotn disease J. Neurochem. 95 2005 210 220 (Pubitemid 41384439)
194. J.M. Van Raamsdonk, J. Pearson, E.J. Slow, S.M. Hossain, B.R. Leavitt, and M.R. Hayden Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease J. Neurosci. 25 2005 4169 4180 (Pubitemid 40563393)
195. J.M. Van Raamsdonk, W.T. Gibson, J. Pearson, Z. Murphy, G. Lu, and B.R. Leavitt Body weight is modulated by levels of full-length huntingtin Hum. Mol. Genet. 15 2006 1513 1523
196. J.M. Van Raamsdonk, Z. Murphy, D.M. Selva, R. Hamidizadeh, J. Pearson, and A. Petersen Testicular degeneration in Huntington disease Neurobiol. Dis. 26 2007 512 520 (Pubitemid 46756321)
197. S. von Hörsten, I. Schmitt, H.P. Nguyen, C. Holzmann, T. Schmidt, T. Walther, M. Bader, R. Pabst, P. Kobbe, J. Krotova, D. Stiller, A. Kask, A. Vaarmann, S. Rathke-Hartlieb, J.B. Schulz, U. Grasshoff, I. Bauer, A.M. Vieira-Saecker, M. Paul, L. Jones, K.S. Lindenberg, B. Landwehrmeyer, A. Bauer, X.J. Li, and O. Riess Transgenic rat model of Huntington's disease Hum. Mol. Genet. 12 2003 617 624 (Pubitemid 36372488)
198. J.P. Vonsattel, and M. DiFiglia Huntington disease J. Neuropathol. Exp. Neurol. 57 1998 369 384 (Pubitemid 28237321)
199. J.P. Wagner, I.B. Black, and E. DiCicco-Bloom Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor J. Neurosci. 19 1999 6006 6016 (Pubitemid 29327934)
200. R.A. Weeks, P. Piccini, A.E. Harding, and D.J. Brooks Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease Ann. Neurol. 40 1996 49 54 (Pubitemid 26250142)
201. V.C. Wheeler, J.K. White, C.A. Gutekunst, V. Vrbanac, M. Weaver, X.J. Li, S.H. Li, H. Yi, J.P. Vonsattel, J.F. Gusella, S. Hersch, W. Auerbach, A.L. Joyner, and M.E. MacDonald Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice Hum. Mol. Genet. 9 2000 503 513 (Pubitemid 30154008)
202. V.C. Wheeler, C.A. Gutekunst, V. Vrbanac, L.A. Lebel, G. Schilling, S. Hersch, R.M. Friedlander, J.F. Gusella, J.P. Vonsattel, D.R. Borchelt, and M.E. MacDonald Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice Hum. Mol. Genet. 11 2002 633 640 (Pubitemid 34285134)
203. L.L. Wu, Y. Fan, S. Li, X.J. Li, and X.F. Zhou Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release J. Biol. Chem. 285 2010 5614 5623
204. G.J. Yohrling, G.C. Jiang, M.M. DeJohn, D.W. Miller, A.B. Young, K.E. Vrana, and J.H. Cha Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology Brain Res. Mol. Brain Res. 119 2003 28 36 (Pubitemid 37324795)
205. Z.X. Yu, S.H. Li, J. Evans, A. Pillarisetti, H. Li, and X.J. Li Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease J. Neurosci. 23 2003 2193 2202 (Pubitemid 36368907)
206. M.S. Zajac, T.Y. Pang, N. Wong, B. Weinrich, L.S. Leang, J.M. Craig, R. Saffery, and A.J. Hannan Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice Hippocampus 20 2010 621 636
207. D. Zhou, and M. DiFiglia Basic fibroblast growth factor enhances the growth of postnatal neostriatal GABAergic neurons in vitro Exp. Neurol. 122 1993 171 188 (Pubitemid 23290400)
208. T. Zigova, V. Pencea, S.J. Wiegand, and M.B. Luskin Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb Mol. Cell. Neurosci. 11 1998 234 245 (Pubitemid 28361411)
209. C. Zuccato, and E. Cattaneo Role of brain-derived neurotrophic factor in Huntington's disease Prog. Neurobiol. 81 2007 294 330 (Pubitemid 46528643)
210. C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza, L. Conti, T. Cataudella, B.R. Leavitt, M.R. Hayden, T. Timmusk, D. Rigamonti, and E. Cattaneo Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat. Genet. 35 2003 76 83 (Pubitemid 37048599)
211. B. Zucker, R. Luthi-Carter, J.A. Kama, A.W. Dunah, E.A. Stern, J.H. Fox, D.G. Standaert, A.B. Young, and S.J. Augood Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1 Hum. Mol. Genet. 14 2005 179 189